2B70.DE vs. NDAQ
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Nasdaq, Inc. (NDAQ).
2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017.
Performance
2B70.DE vs. NDAQ - Performance Comparison
Loading graphics...
2B70.DE vs. NDAQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 3.64% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 30.18% | -7.35% | 2.65% |
NDAQ Nasdaq, Inc. | -10.70% | 12.09% | 43.75% | -6.55% | -5.69% | 72.10% | 15.61% | 36.90% | 13.29% | -1.46% |
Different Trading Currencies
2B70.DE is traded in EUR, while NDAQ is traded in USD. To make them comparable, the NDAQ values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, 2B70.DE achieves a 3.64% return, which is significantly higher than NDAQ's -10.70% return.
2B70.DE
- 1D
- 1.60%
- 1M
- -0.58%
- YTD
- 3.64%
- 6M
- 18.58%
- 1Y
- 29.69%
- 3Y*
- 10.78%
- 5Y*
- 4.95%
- 10Y*
- —
NDAQ
- 1D
- 0.20%
- 1M
- -2.01%
- YTD
- -10.70%
- 6M
- -0.02%
- 1Y
- 5.76%
- 3Y*
- 15.04%
- 5Y*
- 13.03%
- 10Y*
- 16.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. NDAQ — Risk / Return Rank
2B70.DE
NDAQ
2B70.DE vs. NDAQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B70.DE | NDAQ | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.31 | 0.20 | +1.11 |
Sortino ratioReturn per unit of downside risk | 1.83 | 0.46 | +1.37 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.07 | +0.17 |
Calmar ratioReturn relative to maximum drawdown | 2.49 | 0.27 | +2.23 |
Martin ratioReturn relative to average drawdown | 10.78 | 0.69 | +10.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| 2B70.DE | NDAQ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 0.20 | +1.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.24 | 0.55 | -0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.66 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.42 | -0.06 |
Correlation
The correlation between 2B70.DE and NDAQ is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
2B70.DE vs. NDAQ - Dividend Comparison
2B70.DE has not paid dividends to shareholders, while NDAQ's dividend yield for the trailing twelve months is around 1.27%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NDAQ Nasdaq, Inc. | 1.27% | 1.08% | 1.22% | 1.48% | 1.27% | 1.00% | 1.46% | 1.73% | 2.08% | 1.90% | 1.80% | 1.55% |
Drawdowns
2B70.DE vs. NDAQ - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum NDAQ drawdown of -64.79%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and NDAQ.
Loading graphics...
Drawdown Indicators
| 2B70.DE | NDAQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.87% | -68.48% | +37.61% |
Max Drawdown (1Y)Largest decline over 1 year | -15.56% | -21.76% | +6.20% |
Max Drawdown (5Y)Largest decline over 5 years | -30.87% | -32.84% | +1.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -38.31% | — |
Current DrawdownCurrent decline from peak | -1.07% | -15.41% | +14.34% |
Average DrawdownAverage peak-to-trough decline | -10.17% | -23.91% | +13.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.93% | 8.24% | -5.31% |
Volatility
2B70.DE vs. NDAQ - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.80% compared to Nasdaq, Inc. (NDAQ) at 6.32%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| 2B70.DE | NDAQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.80% | 6.32% | +0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 14.03% | 19.84% | -5.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.48% | 28.43% | -5.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.46% | 23.95% | -3.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.78% | 24.67% | -2.89% |